BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sobhani N, Generali D, Zanconati F, Bortul M, Scaggiante B. Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives? World J Clin Oncol 2018; 9(2): 26-32 [PMID: 29651384 DOI: 10.5306/wjco.v9.i2.26]
URL: https://www.wjgnet.com/2218-4333/full/v9/i2/26.htm
Number Citing Articles
1
Ying-Hsiu Su, Amy K. Kim, Surbhi Jain. Liquid biopsies for hepatocellular carcinomaTranslational Research 2018; 201: 84 doi: 10.1016/j.trsl.2018.07.001
2
Periklis Katopodis, Vladimir Anikin, Uday Kishore, Thomas Carter, Marcia Hall, Nizar Asadi, Andreas Polychronis, Emmanouil Karteris. Circulating tumour cells and circulating cell-free DNA in patients with lung cancer: a comparison between thoracotomy and video-assisted thoracoscopic surgeryBMJ Open Respiratory Research 2021; 8(1): e000917 doi: 10.1136/bmjresp-2021-000917
3
Xinglu Jiang, Chenggui Zhao, Xiaobo Fan, Wei Xu, Rui Zhang, Hongbo Xu, Guoqiu Wu. A DNA-modified hydrogel for simultaneous purification, concentration and detection of targeted cfDNA in human serumRSC Advances 2019; 9(6): 3407 doi: 10.1039/C8RA10138H
4
Z. Basit, I. Gull, I. Tipu, Z. Abbas, M. M. Iqbal, M. S. Aslam. Quantitative Analysis of Plasma Circulating Cell-Free Nucleic Acid Based Biomarkers in Patients with Breast CancerMolecular Genetics, Microbiology and Virology 2021; 36(S1): S23 doi: 10.3103/S0891416821050050
5
Kajal Nandi, Rashmi Verma, Rajni Dawar, Binita Goswami. Cell free DNA: revolution in molecular diagnostics – the journey so farHormone Molecular Biology and Clinical Investigation 2020; 41(1) doi: 10.1515/hmbci-2019-0012
6
Evaluation of the cell-free DNA integrity index as a liquid biopsy marker to differentiate hepatocellular carcinoma from chronic liver diseaseFrontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.1024193
7
Min Pan, Jiafeng Lu, Zhiyu Liu, Huajuan Shi, Yunfei Bai, Pingsheng Chen, Qinyu Ge. Integrity of cell‐free DNA in maternal plasma extracellular vesicles as a potential biomarker for non‐invasive prenatal testingInternational Journal of Gynecology & Obstetrics 2022; 158(2): 406 doi: 10.1002/ijgo.13976
8
Navid Sobhani, Marianna Sirico, Daniele Generali, Fabrizio Zanconati, Bruna Scaggiante. Circulating cell-free nucleic acids as prognostic and therapy predictive tools for metastatic castrate-resistant prostate cancerWorld Journal of Clinical Oncology 2020; 11(7): 450-463 doi: 10.5306/wjco.v11.i7.450
9
Domenico Tierno, Gabriele Grassi, Fabrizio Zanconati, Marina Bortul, Bruna Scaggiante. An Overview of Circulating Cell-Free Nucleic Acids in Diagnosis and Prognosis of Triple-Negative Breast CancerInternational Journal of Molecular Sciences 2023; 24(2): 1799 doi: 10.3390/ijms24021799
10
Madhumathy G. Nair, Rakesh S. Ramesh, Chandrakala M. Naidu, Apoorva D. Mavatkar, Snijesh V. P., Vishakha Ramamurthy, Vidya M. Somashekaraiah, Anupama C. E., Kiruthiga Raghunathan, Anuradha Panigrahi, Manjula Das, Sujan K. Dhar, Jyothi S. Prabhu. Estimation of ALU Repetitive Elements in Plasma as a Cost-Effective Liquid Biopsy Tool for Disease Prognosis in Breast CancerCancers 2023; 15(4): 1054 doi: 10.3390/cancers15041054
11
Ugur Gezer, Abel J. Bronkhorst, Stefan Holdenrieder. The Utility of Repetitive Cell-Free DNA in Cancer Liquid BiopsiesDiagnostics 2022; 12(6): 1363 doi: 10.3390/diagnostics12061363
12
Geoffroy Poulet, Fanny Garlan, Sonia Garrigou, Eleonora Zonta, Leonor Benhaim, Marie-Jennifer Carrillon, Audrey Didelot, Delphine Le Corre, Claire Mulot, Philippe Nizard, Frederic Ginot, Audrey Boutonnet-Rodat, Helene Blons, Jean-Baptiste Bachet, Julien Taïeb, Aziz Zaanan, Vanna Geromel, Laurence Pellegrina, Pierre Laurent-Puig, Shu-Fang Wang-Renault, Valerie Taly. Characterization of Plasma Cell-Free DNA Integrity Using Droplet-Based Digital PCR: Toward the Development of Circulating Tumor DNA-Dedicated AssaysFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.639675
13
Marina Bortul, Fabiola Giudici, Domenico Tierno, Daniele Generali, Serena Scomersi, Gabriele Grassi, Cristina Bottin, Maria Rosa Cappelletti, Fabrizio Zanconati, Bruna Scaggiante. A Case–Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer DetectionInternational Journal of Molecular Sciences 2023; 24(10): 8520 doi: 10.3390/ijms24108520
14
Caterina Gianni, Michela Palleschi, Filippo Merloni, Sara Bleve, Chiara Casadei, Marianna Sirico, Giandomenico Di Menna, Samanta Sarti, Lorenzo Cecconetto, Marita Mariotti, Ugo De Giorgi. Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast CancerCancers 2022; 15(1): 96 doi: 10.3390/cancers15010096
15
Gazi Nurun Nahar Sultana, Ferdowsi Akter, S. M. Hasan Israfil, Utpal Chandra Ray, Rumana Akther Jahan, Mohammad Shawkat Ali, Salim Al Din, Shafiqur Rahman, Rezaul Halim, Mohammad Sahajadul Alam. Quantitative analysis of serum cell-free DNA as a predictive and prognostic marker in breast cancer patientsFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1171412
16
Vincent Camus, Fabrice Jardin. Cell-free DNA and the Monitoring of Lymphoma TreatmentPharmacogenomics 2019; 20(18): 1271 doi: 10.2217/pgs-2019-0099
17
Gabriella Cirmena, Martina Dameri, Francesco Ravera, Piero Fregatti, Alberto Ballestrero, Gabriele Zoppoli. Assessment of Circulating Nucleic Acids in Cancer: From Current Status to Future Perspectives and Potential Clinical ApplicationsCancers 2021; 13(14): 3460 doi: 10.3390/cancers13143460
18
Jenna Morgan, Lynda Wyld. Management of Breast Cancer in Older Women2019; : 59 doi: 10.1007/978-3-030-11875-4_5
19
Camila Giro, Alayne M. T. D. Yamada, Felipe José S. M. Cruz, Lilian A. do R. Barros, Beatriz da C. A. Alves, Fernando L. A. Fonseca, Auro del Giglio. Measuring cfDNA integrity as a biomarker for predicting neoadjuvant chemotherapy response in breast cancer patients: a pilot studyBreast Cancer Research and Treatment 2024; 206(2): 329 doi: 10.1007/s10549-024-07366-y
20
Bridgette A Sisson, Jasmina Uvalic, Kevin Kelly, Pavalan Selvam, Andrew N Hesse, Guruprasad Ananda, Harshpreet Chandok, Daniel Bergeron, Lauren Holinka, Honey V Reddi. Technical and Regulatory Considerations for Taking Liquid Biopsy to the Clinic: Validation of the JAX PlasmaMonitorTM AssayBiomarker Insights 2019; 14: 117727191982654 doi: 10.1177/1177271919826545
21
Ludmila A. Alekseeva, Aleksandra V. Sen’kova, Marina A. Zenkova, Nadezhda L. Mironova. Targeting Circulating SINEs and LINEs with DNase I Provides Metastases Inhibition in Experimental Tumor ModelsMolecular Therapy - Nucleic Acids 2020; 20: 50 doi: 10.1016/j.omtn.2020.01.035
22
Mohammad Hadi Abbasian, Ali M. Ardekani, Navid Sobhani, Raheleh Roudi. The Role of Genomics and Proteomics in Lung Cancer Early Detection and TreatmentCancers 2022; 14(20): 5144 doi: 10.3390/cancers14205144
23
Caterina Gianni, Michela Palleschi, Filippo Merloni, Giandomenico Di Menna, Marianna Sirico, Samanta Sarti, Alessandra Virga, Paola Ulivi, Lorenzo Cecconetto, Marita Mariotti, Ugo De Giorgi. Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast CancerInternational Journal of Molecular Sciences 2022; 23(22): 14197 doi: 10.3390/ijms232214197